ClassID:

20185

A61K9/7076 - CPC Classification

Classification description:

Medicinal preparations characterised by special physical form; Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug; Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches; Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising ingredients of undetermined constitution or reaction products thereof, e.g. rosin or other plant resins

Recent Application in this class:
#1
20250090477
2025-03-20

TRANSDERMAL PATCH PROVIDING IMPROVED PERMEABILITY AND COMPOSITION

#2
20240122871
2024-04-18

TRANSDERMAL CANNABINOID TEMPORARY TATTOO

#3
20230074629
2023-03-09

DICLOFENAC SODIUM CONTAINING PATCH

#4
20220370375
2022-11-24

PAIN RELIEVING PATCH COMPRISING A PROPOLIS COMPOSITION AND ASSOCIATED METHODS

#5
20220296502
2022-09-22

Non-aqueous patch

#6
20220265567
2022-08-25

Method for treating osteoarthritis

#7
20220117907
2022-04-21

Transdermal patch providing improved permeability and composition

#8
20210330601
2021-10-28

Transdermal therapeutic system containing asenapine

#9
20210154154
2021-05-27

PREVENTING CRYSTALLIZATION OF ACTIVE INGREDIENTS IN TRANSDERMAL DELIVERY SYSTEMS

#10
20210008001
2021-01-14

Living body-adhesive sheet

#11
20210000754
2021-01-07

TRANSDERMAL PATCH PROVIDING IMPROVED PERMEABILITY AND COMPOSITION

#12
20200405655
2020-12-31

METHOD FOR ACCELERATING WOUND HEALING

#13
20200375915
2020-12-03

MATRIX ADHESIVE PATCH AND PROCESS FOR THE PREPARATION THEREOF

#14
20200306203
2020-10-01

Rotigotine-containing patch

#15
20200188317
2020-06-18

Transdermal therapeutic system containing asenapine

#16
20200155360
2020-05-21

NANO-EMULSIFIED CANNABINOID OR OILS IN ATHLETIC TAPE AND OTHER PRODUCTS

#17
20190336454
2019-11-07

Transdermal therapeutic system containing asenapine

#18
20190125693
2019-05-02

KINESIOLOGY TAPE HAVING CANNABIS-DERIVED COMPOUNDS

#19
20190083416
2019-03-21

Transdermal device including porous microparticles

#20
20180235902
2018-08-23

Patch

#21
20180140513
2018-05-24

Skin Cover and Medical Device

#22
20180015049
2018-01-18

Adhesive patch

#23
20170296692
2017-10-19

TRANSDERMAL THERAPEUTIC SYSTEMS CONTAINING 4-N-BUTYL-RESORCINOL

#24
20170071872
2017-03-16

Fentanyl-containing patch for external use

#25
20160271075
2016-09-22

Fentanyl-containing adhesive preparation for external use

#26
20160128950
2016-05-12

TAPE HAVING TRANSDERMAL ANALGESIC PROPERTIES

#27
20150297532
2015-10-22

Ropinirole-containing adhesive patch

#28
20150258036
2015-09-17

Transdermal drug delivery system containing donepezil

#29
20150148758
2015-05-28

MIRTAZAPINE-CONTAINING TRANSDERMALLY-ABSORBABLE SKIN-ADHESIVE PREPARATION

#30
20150045748
2015-02-12

Transdermal device including porous microparticles

#31
20140371693
2014-12-18

Adhesive preparation

#32
20140335151
2014-11-13

Patch containing non-steroidal anti-inflammatory drug

#33
20140303574
2014-10-09

Adhesive patch assembly with overlay liner and system and method for making same

#34
20140234396
2014-08-21

EXTERNAL PATCHES CONTAINING ETOFENAMATE

#35
20140171886
2014-06-19

Patch for treatment of eyelid disease containing clobetasol

#36
20140171509
2014-06-19

Non-aqueous patch

#37
20140109916
2014-04-24

Transdermal delivery of hormones with low concentration of penetration enhancers

#38
20140005617
2014-01-02

Fentanyl transdermal patch

#39
20140005615
2014-01-02

External preparation kit

#40
20130005800
2013-01-03

COMPOSITION FOR TRANSDERMAL OR TRANSMUCOSAL ADMINISTRATION

#41
20120283671
2012-11-08

Anti-inflammatory analgesic adhesive patch for external use

#42
20120282303
2012-11-08

PERCUTANEOUS ABSORPTION PREPARATION COMPRISING ANTI-DEMENTIA DRUG

#43
20120259020
2012-10-11

Transdermal therapeutic patches containing 4-N-butylresorcinol

#44
20120215185
2012-08-23

Transdermal delivery system for the administration of rotigotine

#45
20120197221
2012-08-02

TRANSEPIDERMAL DRUG DELIVERY SYSTEM CONTAINING RIVASTIGMINE

#46
20120178788
2012-07-12

METHOD FOR SUPPRESSING ESTERIFICATION OF PHARMACEUTICAL COMPOSITION

#47
20120171278
2012-07-05

Percutaneous absorption type plaster

#48
20120090275
2012-04-19

ADHESIVE PATCH-CONTAINING PACKAGE BAG AND METHOD FOR STORING ADHESIVE PATCH

#49
20120071511
2012-03-22

Fentanyl-containing adhesive preparation for external use

#50
20110243985
2011-10-06

Self-adhesive matrix system comprising a styrene block copolymer

#51
20110195109
2011-08-11

Adhesive skin patch and packaged product

#52
20110151001
2011-06-23

PHARMACEUTICAL COMPOSITION FOR EXTERNAL APPLICATION CONTAINING PROCHLORPERAZINE

#53
20110124727
2011-05-26

Oxybuprocaine-Containing Analgesic/Antipruritic External Preparation

#54
20110028555
2011-02-03

Antiinflammatory and analgesic preparation for external use

#55
20100322999
2010-12-23

Fentanyl-containing patch for external use

#56
20100318042
2010-12-16

Adhesive patch

#57
20100280090
2010-11-04

Tape preparation comprising etodolac in ionic liquid form

#58
20100150992
2010-06-17

Methods for Treatment of Ophthalmic Disease of an External Ophthalmic Tissue

#59
20100137429
2010-06-03

COMPOSITION FOR TRANSDERMAL OR TRANSMUCOSAL ADMINISTRATION

#60
20100055160
2010-03-04

Diclofenac sodium patches for topical treatment of pain

#61
20100055159
2010-03-04

PERCUTANEOUS PREPARATIONS

#62
20100047328
2010-02-25

Adhesive preparation

#63
20100047325
2010-02-25

ANALGESIC ANTI-INFLAMMATORY PATCHES FOR TOPICAL USE

#64
20100041758
2010-02-18

Adhesive preparation

#65
20100028411
2010-02-04

Adhesive skin patch and method for evaluation of adhesive skin patch

#66
20100022614
2010-01-28

PHARMACEUTICAL COMPOSITION FOR EXTERNAL APPLICATION AND ADHESIVE SKIN PATCH

#67
20100003312
2010-01-07

External skin patch

#68
20090291140
2009-11-26

TREATMENT OF DYSMENORRHEA VIA TRANSDERMAL ADMINISTRATION OF NONSTEROIDAL ANTI-INFLAMMATORY DRUGS

#69
20090285877
2009-11-19

Percutaneous absorption preparation containing palonosetron

#70
20090258952
2009-10-15

Method for avoiding crystallization of anti-inflammatory agent in plaster formulation

#71
20090239828
2009-09-24

Adhesive preparation

#72
20090220580
2009-09-03

Percutaneous Absorption Formulation

#73
20090149794
2009-06-11

Adhesive preparation

#74
20090043236
2009-02-12

Skin patch

#75
20090022778
2009-01-22

External plaster containing flurbiprofen

#76
20090004256
2009-01-01

Lowly irritative adhesive patch

#77
20080188509
2008-08-07

Transdermal Preparations and Method for Relieving Side Effects in Pergolide Therapy

#78
20080113010
2008-05-15

Nonaqueous preparation for percutaneous absorption containing nonsteroidal anti-inflammatory analgesic

#79
20080089926
2008-04-17

External patches containing etofenamate

#80
20080063698
2008-03-13

Crystallization inhibition of drugs in transdermal drug delivery systems and methods of use

#81
20080038328
2008-02-14

Pasting Preparation

#82
20080031835
2008-02-07

Antiinflammatory and analgesic preparation for external use

#83
20070232629
2007-10-04

Adhesive Patch

#84
20070224254
2007-09-27

Transdermal delivery patch

#85
20070207088
2007-09-06

Anti-Inflammatory Analgesic Adhesive Patch

#86
20070184097
2007-08-09

Adhesive preparations

#87
20070166360
2007-07-19

External preparation

#88
20070154531
2007-07-05

External patch preparation comprising ketoprofen and a specific UV screening agent

#89
20070083139
2007-04-12

Adhesive preparations

#90
20070082037
2007-04-12

Transdermal preparations and method for relieving side effects in pergolide therapy

#91
20070077282
2007-04-05

Adhesive containing polyisoprene, sis copolymer, and solid/liquid polyisobutylene for external use on skin

#92
20070065493
2007-03-22

External patch containing estrogen and/or progestogen

#93
20070054952
2007-03-08

Anti-inflammatory analgesic for external use

#94
20070036847
2007-02-15

Lowly irritative adhesive patch

#95
20070009588
2007-01-11

Adhesive patch for fentanyl administration

#96
20060198880
2006-09-07

Ultraviolet-shielding type patch

#97
20060188554
2006-08-24

Transdermal absorption preparation

#98
20060172002
2006-08-03

Patch containing nonsteroidal anti-inflammatory and analgesic agent

#99
20060165763
2006-07-27

Pasting agent

#100
20060110433
2006-05-25

Adhesive patch

#101
20060036220
2006-02-16

Percutaneous absorption preparation for treating ophthalmic disease, use thereof and method for migration of ophthalmic remedy into topical tissue in eye

#102
20060015054
2006-01-19

External plaster containing 4-biphenylacetic acid

#103
20050288232
2005-12-29

Proline ester and preparation containing the same for percutaneous administration

#104
20050266063
2005-12-01

Adhesive patch

#105
20050260255
2005-11-24

Adhesive patch

#106
20050244486
2005-11-03

Topical methadone compositions and methods for using the same

#107
20050220852
2005-10-06

Patches containing tulobuterol

#108
20050215934
2005-09-29

Medicinal patch that leaves less adhesive residue when removed

#109
20050187212
2005-08-25

Pharmaceutical composition for topical delivery of meloxicam

#110
20050175676
2005-08-11

Patch with improved anchoring properties between a substrate and an adhesive

#111
20050142175
2005-06-30

Transdermal delivery of hormones without the need of penetration enhancers

#112
20050129748
2005-06-16

Percutaneous absorption type plaster

#113
20050106186
2005-05-19

Percutaneous preparations

#114
20050079206
2005-04-14

Transdermal delivery system for the administration of rotigotine

#115
20050042269
2005-02-24

Plaster having laminated support

#116
20050020658
2005-01-27

Selective cyclooxygenase-2 inhibitor patch

#117
20050019382
2005-01-27

Method for the continuous production and coating of self-adhesive compounds on the basis of SBC that includes at least one pharmaceutically active substance